Adempas (ADMP, ADTP, ADQS, ADAP, ADFT)

Adverse Event (AE) (shall also apply to medical devices and combination products used in conjunction with Product) is any untoward medical occurrence in a patient or clinical trial subject administered a medicinal product and which does not necessarily have a causal relationship with this treatment.

The following cases, with or without an AE, must be reported

• Exposure via mother/father (exposure during conception, pregnancy, childbirth and breastfeeding)

• Drug interactions

• Addiction I Dependence

• Withdrawal syndrome

• Lack of Drug Effect I Lack of Effect

• Suspected transmission of an infectious agent

• Accidental exposure

• Accidental or intentional misuse, abuse, or overdose

• Medication error including, but not limited to, inappropriate administration

• Intentional product use issues resulting in an AE

• Occupational and environmental exposure

• Unexpected therapeutic benefit (pre-existing condition improved)
